Treatment of Metastatic Colorectal Cancer in the Elderly
作者： Hong L. Nguyen , Jimmy Hwang
DOI: 10.1007/S11864-009-0111-7
关键词:
摘要: Metastatic colorectal cancer (CRC) is the second leading cause of related mortality in United States. The median age patients at diagnosis over 70, so as American population ages, it can be expected that incidence CRC will also increase. There limited prospective data regarding safety and efficacy chemotherapy elderly with metastatic CRC. However, are available suggest a good performance status have similar likelihood response to currently chemotherapy, though perhaps somewhat higher toxicities such myelosuppression. This paper reviews recommendations for treatment this patient population.
springer.com
sci-hub.se 参考文章(32)
Arié Figer, Nathalie Perez-Staub, Elisabeth Carola, Christophe Tournigand, Gerard Lledo, Michel Flesch, Ramon Barcelo, Andre Cervantes, Thierry André, Philippe Colin, Christophe Louvet, Aimery de Gramont, FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer. ,vol. 110, pp. 2666- 2671 ,(2007) , 10.1002/CNCR.23091
Pasquale Comella, Donato Natale, Antonio Farris, Antonio Gambardella, Luigi Maiorino, Bruno Massidda, Rossana Casaretti, Salvatore Tafuto, Vito Lorusso, Silvana Leo, Michele Cannone, Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma Cancer. ,vol. 104, pp. 282- 289 ,(2005) , 10.1002/CNCR.21167
L. M. Pasetto, C. Falci, G. Sinigaglia, A. A. Brandes, S. Monfardini, How many colorectal cancer (CRC) patients older than 70 years may be safely treated with bevacizumab Journal of Clinical Oncology. ,vol. 24, pp. 13589- 13589 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.13589
J. Souglakos, A. Pallis, S. Kakolyris, D. Mavroudis, N. Androulakis, C. Kouroussis, S. Agelaki, N. Xenidis, G. Milaki, V. Georgoulias, Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial Oncology. ,vol. 69, pp. 384- 390 ,(2005) , 10.1159/000089992
I Chau, A R Norman, D Cunningham, J S Waters, C Topham, G Middleton, M Hill, P J Ross, R Katopodis, G Stewart, J R Oates, Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy. British Journal of Cancer. ,vol. 91, pp. 1453- 1458 ,(2004) , 10.1038/SJ.BJC.6602169
Heather-Jane Au, Karen E. Mulder, Anthony L.A. Fields, Systematic review of management of colorectal cancer in elderly patients. Clinical Colorectal Cancer. ,vol. 3, pp. 165- 171 ,(2003) , 10.3816/CCC.2003.N.022
J Feliu, , A Salud, P Escudero, L Lopez-Gómez, M Bolaños, A Galán, J-M Vicent, A Yubero, F Losa, J De Castro, M Á de Mon, E Casado, M González-Barón, XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer. British Journal of Cancer. ,vol. 94, pp. 969- 975 ,(2006) , 10.1038/SJ.BJC.6603047
Daniel J. Sargent, Richard M. Goldberg, Stacy D. Jacobson, John S. Macdonald, Roberto Labianca, Daniel G. Haller, Lois E. Shepherd, Jean François Seitz, Guido Francini, A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. The New England Journal of Medicine. ,vol. 345, pp. 1091- 1097 ,(2001) , 10.1056/NEJMOA010957
James S. Goodwin, William C. Hunt, Jonathan M. Samet, Determinants of cancer therapy in elderly patients Cancer. ,vol. 72, pp. 594- 601 ,(1993) , 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#
Friedemann Honecker, Claus-Henning K??hne, Carsten Bokemeyer, Colorectal cancer in the elderly: is palliative chemotherapy of value? Drugs & Aging. ,vol. 20, pp. 1- 11 ,(2003) , 10.2165/00002512-200320010-00001